Broad collateral damage of drugs against the gut microbiome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Cross hybridization Inference for Phylogenetic Resolution (CIPHR)-FISH enables microbiome imaging with strain level taxonomic resolution.bioRxiv : the preprint server for biology · 2026
   Article
2. Advancing our understanding of the influence of drug induced changes in the gut microbiome on bone health.Frontiers in endocrinology · 2023
   Review
3. Esterases FromFrontiers in microbiology · 2022
   Article
4. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2021
   Article
5. Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption.Bioengineering (Basel, Switzerland) · 2020
   Review
6. Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model.Scientific reports · 2020
   Article
7. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression.Journal of clinical medicine · 2020
   Review
8. Xenosiderophore Utilization Promotes Bacteroides thetaiotaomicron Resilience during Colitis.Cell host & microbe · 2020
   Article
9. Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab.Targeted oncology · 2019
   Article

Corrections and comments

• Comment on
  Extensive impact of non-antibiotic drugs on human gut bacteria.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as